avelumab,pelareorep,paclitaxel
merck,pfizer,oncolytics biotech
['breast', 'mbc', 'bracelet-1', 'bcsm']
oncolytics biotech announces updated randomized phase 2 data from bracelet-1 metastatic breast cancer trial that show pelareorep driving robust increases in progression-free survival and confirmed overall response rate. #asco23 #bio23 #mbc #bcsm 